Susquehanna International Group’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-18,100
Closed -$507K 10964
2016
Q4
$507K Sell
18,100
-59,900
-77% -$1.68M ﹤0.01% 6977
2016
Q3
$2.14M Buy
78,000
+64,000
+457% +$1.76M ﹤0.01% 3459
2016
Q2
$305K Buy
+14,000
New +$305K ﹤0.01% 6926
2015
Q3
Sell
-29,100
Closed -$721K 11037
2015
Q2
$721K Sell
29,100
-37,100
-56% -$919K ﹤0.01% 6883
2015
Q1
$1.67M Sell
66,200
-41,000
-38% -$1.03M ﹤0.01% 4677
2014
Q4
$2.52M Buy
107,200
+83,700
+356% +$1.96M ﹤0.01% 4018
2014
Q3
$535K Buy
23,500
+5,700
+32% +$130K ﹤0.01% 7085
2014
Q2
$435K Buy
+17,800
New +$435K ﹤0.01% 7749
2013
Q4
Sell
-15,500
Closed -$332K 9855
2013
Q3
$332K Buy
+15,500
New +$332K ﹤0.01% 7068

Other funds holding QGENF

Susquehanna International Group's QGENF Position: Q1 2017 in Review

Susquehanna International Group sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 47,086 shares — an estimated $1.32M sold.

Susquehanna International Group first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $5.26M in Q2 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Susquehanna International Group reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Susquehanna International Group sold 47,086 QIAGEN NV shares in Q1 2017, an estimated $1.32M.
  • Susquehanna International Group first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • Susquehanna International Group's QIAGEN NV position peaked at $5.26M in Q2 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.